Snowball logo
logo
SMDP

Sumitomo Pharma Co. Ltd

SMDPY β€’ PINK
$10.325$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
68,133,845.4555,544314,558398,832480,631.2480,980.6
COGS
19,116,067.3178,919126,577153,437208,245.5216,440.5
Gross Profit
49,017,778.2376,625187,981245,395272,385.7264,540.1
Operating Expenses & Income
Operating Income
7,328,067.1(76,979)(354,194)28,80453,375.949,000.9
Total Operating Expenses
41,689,711.1453,604542,175216,591219,009.8215,539.2
R&D Expenses
11,545,896.8131,858112,63749,86546,649.347,897
Selling General & Admin Expenses
21,845,143.9279,355429,538180,605162,557-
Earnings from Continuing Operations
Interest Expense
(371,062.9)(3,159)(4,277)(13,500)(10,806.7)(7,819.8)
Interest Income
3,136,029.232,21836,0222,3073,198-
Income Tax Expense
5,153,638.348,794(8,185)(6,024)(6,914.3)(6,075.5)
Net Income
Net Income
6,863,204.3(74,512)(314,969)23,634113,309.8114,328.3
Supplemental
EBIT
10,464,096.3(44,761)(318,837)31,11153,375.9109,168.5
EBITDA
15,129,513.1(3,498)(281,072)56,67375,415.5129,722
In millions of USD, except % and values per 1 share